Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline
Authors
Keywords
<em class="EmphasisTypeItalic ">CYP2A6</em>, <em class="EmphasisTypeItalic ">CYP2B6</em>, Nicotine metabolism, Smoking cessation, Polymorphism, rs8109525
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-11
DOI
10.1007/s00228-019-02731-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women
- (2018) Paulo Roberto Xavier Tomaz et al. BMC Medical Genetics
- É improvável que a cirurgia seja suficiente para que o paciente pare de fumar 24 horas antes da internação hospitalar
- (2018) Igor Maia Marinho et al. Revista Brasileira de Anestesiologia
- Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages
- (2017) Gloria Pérez-Rubio et al. GENE
- Pharmacogenetic Optimization of Smoking Cessation Treatment
- (2017) Meghan J. Chenoweth et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting
- (2016) André Pacheco Silva et al. BMC Cardiovascular Disorders
- Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio
- (2016) Cheyenne E. Allenby et al. Journal of Neuroimmune Pharmacology
- Effects of aging on the effectiveness of smoking cessation medication
- (2016) Jaqueline Scholz et al. Oncotarget
- Nicotine dependence in an isolated population of Kashubians from North Poland: a population survey
- (2015) Alicja Sieminska et al. BMC PUBLIC HEALTH
- CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy
- (2015) Paulo Roberto Xavier Tomaz et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
- (2015) Caryn Lerman et al. Lancet Respiratory Medicine
- Smoking cessation and weight gain in patients with cardiovascular disease or risk factor
- (2014) Jaqueline S. Issa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- CYP2B6 Non-Coding Variation Associated with Smoking Cessation Is Also Associated with Differences in Allelic Expression, Splicing, and Nicotine Metabolism Independent of Common Amino-Acid Changes
- (2013) A. Joseph Bloom et al. PLoS One
- Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI
- (2012) Deborah W. Tang et al. NEUROIMAGE
- Rapid Nicotine Clearance is Associated with Greater Reward and Heart Rate Increases from Intravenous Nicotine
- (2012) Mehmet Sofuoglu et al. NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Coadministration of Varenicline, Bupropion, and Serotonin Reuptake Inhibitors in a Smoking Cessation Program in the Real-Life Setting
- (2012) Jaqueline S. Issa et al. NICOTINE & TOBACCO RESEARCH
- Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy
- (2011) Jane E. Sarginson et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
- (2011) David P King et al. NEUROPSYCHOPHARMACOLOGY
- Constitutional mechanisms of vulnerability and resilience to nicotine dependence
- (2009) N Hiroi et al. MOLECULAR PSYCHIATRY
- Role of cytochrome P450 in drug interactions
- (2008) Zakia Bibi Nutrition & Metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More